- Principal Investigator - CellRADx, Point-of-Care Biodosimetry Program- Scientific Advisor - CytoRADx, High-throughput Biodosimetry Program

- Validation, Design & Development Lead - CytoRADx, High-throughput Biodosimetry Program- Technical Lead - CellRADx, Point-of-Care Biodosimetry Program

Technical Consulting-Business development. Grant and contract proposal writing for private and federal agency funding -Product development and regulatory strategy for diagnostic medical devices-Quality system optimization for medical device companies-Artificial Intelligence implementation strategy for biotechnology and pharmaceutical companies Philanthropy-Educational presentations and videos on science concepts-Science and career fairs

Assay Development and Assay Services Departments-Spearheaded development and commercialization of biomarker assays for numerous indications-Designed and optimized immunoassays for targets related to biodosimetry, cardiovascular disease, immunology, metabolism, neurobiology, oncology, and toxicology-Developed assays in collaboration with nonprofit organizations, KOLs from academic medical centers, and pharmaceutical partners-Validated assays internally and externally, across laboratories and organizations-Fostered relationships and managed contributions of stakeholders across internal departments, including Marketing and Quality Assurance-Drafted customer-facing scientific communications, e.g. package inserts, posters, and presentations, for marketing and training on the uses, benefits, and capabilities of company products-Implemented unique approaches to drastically reduce the time required to launch new products

Department of Neurology & NeurosurgeryAlfredo Quiñones-Hinojosa Lab-Developed institutional review board-approved protocols that employed donated patient samples and clinical data to study state-of-the-art diagnostic tools and treatment methods for brain cancer-Collaborated with physician scientists in oncology to investigate new drug targets, e.g. proton exchanger NHE9 and glycogenolytic enzyme G6CP, implicated in cancer metabolism and invasion-Engineered cell-based approaches for delivery of therapeutic proteins, e.g. BMP4, to tumors-Delivered numerous presentations on cutting edge research to patients, physicians, and fellow scientists-Mentored 3 undergraduate students, who have advanced to graduate careers in medicine and scientific research. Trained numerous researchers, at various career levels, in nanotechnology-Research partnership generated six publications and over $500K in additional grants and awards

Department of Biomedical EngineeringAndre Levchenko LabDepartment of NeurosurgeryAlfredo Quiñones-Hinojosa Lab (co-adviser)-Initiated NIH R01 grant-awarded partnership with opinion-leading neurosurgeons and oncologists to study brain cancer, specifically glioblastoma, and modern therapeutic techniques-Coordinated joint meetings, experimental efforts, and interdisciplinary training across partner labs-Studied the effects of growth factor signaling, e.g. PDGF, ion transport through NKCC1, and mechanical cues from the tumor microenvironment on cancer cell motility and invasiveness-Designed and utilized novel micro- and nanotechnological tools to study cell behaviors, e.g. migration, adhesion, intercellular signaling, and signal transduction, in unprecedented ways-Developed diagnostic device to predict clinical outcomes, e.g. tumor recurrence and location, based on cell migratory responses to mechanical and biochemical cues, as well as receptor expression